Juventas is committed to establishing partnerships with leading corporate, academic, and clinical centers around the world, in order to expand and develop its product pipeline. In development of our lead product, SDF-1 for the treatment of heart failure, we have on-going collaborative research programs with The Cleveland Clinic, Center for Stem Cell & Regenerative Medicine, Global Cardiovascular Innovation Center, and Weill Cornell Medical College. As Juventas continues to advance its product pipeline and expand into additional clinical areas, we will look to build upon these relationships and initiate new partnerships.
For additional information on partnering with Juventas please send inquiries to info@juventasinc.com.
For additional information on partnering with Juventas please send inquiries to info@juventasinc.com.